#GynCSM Transcript
Healthcare social media transcript of the #GynCSM hashtag.
– ().
See #GynCSM Influencers/Analytics.
| Profile | Tweet |
|---|---|
 | GYN Cancer | #GYNCSM @gyncsm Welcome to #gyncsm - a passionate community for gynecologic cancer survivors, caregivers, advocates and health care providers. |
 | Dee Sparacio @womenofteal RT @gyncsm: Welcome to #gyncsm - a passionate community for gynecologic cancer survivors, caregivers, advocates and health care providers. |
| GYN Cancer | #GYNCSM @gyncsm Our co-moderators are @womenofteal @btrfly12 Our health care moderators are @ShannonWestin @temkins @journeycancer and our mental health moderator @DrBeckerSchutte We start out with brief intro’s - Please take a moment to introduce yourself. #gyncsm |
 | Christina Lizaso @btrfly12 Christina Lizaso – passionate re: community engagement and cancer care. I’ll be moderating as @gyncsm today. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: Our co-moderators are @womenofteal @btrfly12 Our health care moderators are @ShannonWestin @temkins @journeycancer and our mental health moderator @DrBeckerSchutte We start out with brief intro’s - Please take a moment to introduce yourself. #gyncsm |
| Dee Sparacio @womenofteal Dee here! Dx with #ovca Stage3B 2005, recurrence 2008, Ovarian Cancer research advocate, blogger, co-Author of “100 Questions and Answers about Ovarian cancer” & co-moderator #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm If you prefer to “listen only” during the chat, we'd love for you to tweet "#gyncsm" when you join - just to let us know you are here. Please continue intro's and welcomes - we'll start in w/ the "ground rules" :) and tips! |
| Dee Sparacio @womenofteal RT @gyncsm: If you prefer to “listen only” during the chat, we'd love for you to tweet "#gyncsm" when you join - just to let us know you are here. Please continue intro's and welcomes - we'll start in w/ the "ground rules" :) and tips! |
| GYN Cancer | #GYNCSM @gyncsm The #gyncsm chat promotes community in a public forum. Chats are an open discussion and all are welcome to share from their experiences and perspectives. Learn more about risks/benefits: https://t.co/TipZUv1jQy |
| Dee Sparacio @womenofteal RT @gyncsm: The #gyncsm chat promotes community in a public forum. Chats are an open discussion and all are welcome to share from their experiences and perspectives. Learn more about risks/benefits: https://t.co/TipZUv1jQy |
 | Suzie Siegel @SuzieSiegel Survivor of metastatic vaginal #leiomyosarcoma. My head's still swimming from #ASCO22 online. #gyncsm |
| Dee Sparacio @womenofteal #gyncsm tagged resources and referrals are not a substitute for speaking with your doctor who understands your individual needs and history. |
| GYN Cancer | #GYNCSM @gyncsm #gyncsm is not a forum for individual medical advice. Resources and referrals and provided solely for information and convenience. |
| Dee Sparacio @womenofteal @SuzieSiegel Hi Suzie - Yes there were lots of studies on sarcomas and other rare cancers. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm Are you new to tweet chats? Follow hashtag #gyncsm under "Explore" and "Latest" and include it in every tweet during the next hour to engage with others about this topic. #gyncsm |
 | Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @gyncsm: Our co-moderators are @womenofteal @btrfly12 Our health care moderators are @ShannonWestin @temkins @journeycancer and our mental health moderator @DrBeckerSchutte We start out with brief intro’s - Please take a moment to introduce yourself. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: Are you new to tweet chats? Follow hashtag #gyncsm under "Explore" and "Latest" and include it in every tweet during the next hour to engage with others about this topic. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm Welcome to those joining and also those “listening in”. Be sure to tweet #gyncsm so we know you are here. You can always tweet, DM or email us with questions/comments after the chat is over. https://t.co/XYaP3OTgsG #gyncsm |
 | Sarah Temkin @temkins RT @gyncsm: Our co-moderators are @womenofteal @btrfly12 Our health care moderators are @ShannonWestin @temkins @journeycancer and our mental health moderator @DrBeckerSchutte We start out with brief intro’s - Please take a moment to introduce yourself. #gyncsm |
| Dee Sparacio @womenofteal Remember - Twitter is an open social network and posts are public. Use a Direct Message to exchange email addresses/personal information.#gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin Hi all! Gyn onc from @MDAndersonNews - excited to be here for the chat! #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm Tonight on #gyncsm we’ll be discussing “Gyn Cancer Research News”. You can find the 6 topic areas we’ll cover on today’s chat on our #gyncsm blog: https://t.co/vPchWkrJQI |
| Sarah Temkin @temkins RT @gyncsm: Are you new to tweet chats? Follow hashtag #gyncsm under "Explore" and "Latest" and include it in every tweet during the next hour to engage with others about this topic. #gyncsm |
| Sarah Temkin @temkins RT @gyncsm: Tonight on #gyncsm we’ll be discussing “Gyn Cancer Research News”. You can find the 6 topic areas we’ll cover on today’s chat on our #gyncsm blog: https://t.co/vPchWkrJQI |
| Christina Lizaso @btrfly12 RT @gyncsm: Tonight on #gyncsm we’ll be discussing “Gyn Cancer Research News”. You can find the 6 topic areas we’ll cover on today’s chat on our #gyncsm blog: https://t.co/vPchWkrJQI |
| Dee Sparacio @womenofteal Thank you to all who have tweeted valuable information to our community during the past month using #gyncsm along with the #ASCO22 hashtag this pas weekend. We appreciate those who helped promote tonight's chat. |
| GYN Cancer | #GYNCSM @gyncsm We’ll use a topic format with T1:; T2: etc. Please include the corresponding T#: at the front of your comment or answer. We will also end our chat with a chance to share TIL: thoughts standing for “Today I Learned”. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: Tonight on #gyncsm we’ll be discussing “Gyn Cancer Research News”. You can find the 6 topic areas we’ll cover on today’s chat on our #gyncsm blog: https://t.co/vPchWkrJQI |
| Dee Sparacio @womenofteal RT @gyncsm: We’ll use a topic format with T1:; T2: etc. Please include the corresponding T#: We’ll use a topic format with T1:; T2: etc. Please include the corresponding T#: at the front of your comment or answer. We will also end our chat with a chance to share TIL: thoughts standing for “Today I Learned”. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm Here comes Topic1 (T1:)... #gyncsm |
 | Gary L. Thompson @garyleethompson Listening in to #gyncsm tonight… virtual hugs from Texas to y’all!! 🤗🤗 |
| GYN Cancer | #GYNCSM @gyncsm T1: What #SGOMtg presentations did you personally find of most interest? Anything practice-changing? #gyncsm |
| Dee Sparacio @womenofteal @garyleethompson Great to have you joining us Gary! #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: T1: T1: What #SGOMtg presentations did you personally find of most interest? Anything practice-changing? #gyncsm |
| Suzie Siegel @SuzieSiegel T1. @SamBoseMD's study on RAD51 foci formation predicting DNA damage repair deficiency, and how PARP inhibitors may help more women with gyn #leiomyosarcoma. #gyncsm |
| Christina Lizaso @btrfly12 T1: I appreciated the study on older cervical cancer patients and how the current guidelines to stop screening after 65 are not working well in practice as there are conditions that need to be present to stop. #gyncsm https://t.co/4yR0wbSsXj |
| Sarah Temkin @temkins RT @btrfly12: T1: T1: I appreciated the study on older cervical cancer patients and how the current guidelines to stop screening after 65 are not working well in practice as there are conditions that need to be present to stop. #gyncsm https://t.co/4yR0wbSsXj |
| Gary L. Thompson @garyleethompson @womenofteal Thank you… for all the folks I saw IRL at #ASCO22 still crazy how many I didn’t!! Such a big event. #gyncsm |
| Christina Lizaso @btrfly12 T1: #gyncsm The study on packing changes that could not only save healthcare money but save patients money was so practical and nice to see something actionable right away. See thread by @fumikochino : |
| Dee Sparacio @womenofteal T1: For me Emeline Aviki's ,presentation on “Overspending on Dose-Specific Packaging of Lenvatinib for Endometrial Cancer,” which led to @EisaiUS announcing that it will expand its dose exchange program to cover dose reductions. #gyncsm |
| Dee Sparacio @womenofteal RT @SuzieSiegel: T1. @SamBoseMD's study on RAD51 foci formation predicting DNA damage repair deficiency, and how PARP inhibitors may help more women with gyn #leiomyosarcoma. #gyncsm |
| Christina Lizaso @btrfly12 RT @SuzieSiegel: T1. @SamBoseMD's study on RAD51 foci formation predicting DNA damage repair deficiency, and how PARP inhibitors may help more women with gyn #leiomyosarcoma. #gyncsm |
| Dee Sparacio @womenofteal RT @btrfly12: T1: T1: I appreciated the study on older cervical cancer patients and how the current guidelines to stop screening after 65 are not working well in practice as there are conditions that need to be present to stop. #gyncsm https://t.co/4yR0wbSsXj |
| Sarah Temkin @temkins RT @btrfly12: T1: T1: #gyncsm The study on packing changes that could not only save healthcare money but save patients money was so practical and nice to see something actionable right away. See thread by @fumikochino : |
 | Matthew Katz, MD 🟦 @subatomicdoc RT @btrfly12: T1: T1: #gyncsm The study on packing changes that could not only save healthcare money but save patients money was so practical and nice to see something actionable right away. See thread by @fumikochino : |
| Dee Sparacio @womenofteal Yup that one was a good one. #gyncsm |
 | Lisa Davis Budzinski @lisadbudzinski RT @gyncsm: Tonight on #gyncsm we’ll be discussing “Gyn Cancer Research News”. You can find the 6 topic areas we’ll cover on today’s chat on our #gyncsm blog: https://t.co/vPchWkrJQI |
| Dee Sparacio @womenofteal @EisaiUS https://t.co/ExUMQyeRNV #gyncsm |
 | Tobey @BRCAinfo Hi #gyncsm Sorry I’m late |
 | Martina Murphy, MD @DrMMurphy @gyncsm @womenofteal @btrfly12 @ShannonWestin @temkins @journeycancer @DrBeckerSchutte Hi all! Joining a bit late, tonight. Martina Murphy - Med gyn onc at UF. #gyncsm |
| Christina Lizaso @btrfly12 T1: At #SGOmtg this year it was nice to see there is some progress being made in ovarian cancer. It was also nice to see the other gyn cancers, rare cancers and disparities well represented. #gyncsm |
| Dee Sparacio @womenofteal @BRCAinfo Hi Tobey . No problem we just started. Glad you are here. #gyncsm |
| Dee Sparacio @womenofteal @DrMMurphy @gyncsm @btrfly12 @ShannonWestin @temkins @journeycancer @DrBeckerSchutte Hello!!!! Thanks for joining us. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm We're wrapping up on sharing studies from #SGOmtg that were of interest, but as you join you can chime in even as we move along to Topic2... #gyncsm |
 | Emeline Aviki, MD, MBA @EmelineAvikiMD RT @btrfly12: T1: T1: #gyncsm The study on packing changes that could not only save healthcare money but save patients money was so practical and nice to see something actionable right away. See thread by @fumikochino : |
| Dee Sparacio @womenofteal RT @gyncsm: We're wrapping up on sharing studies from #SGOmtg that were of interest, but as you join you can chime in even as we move along to Topic2... #gyncsm |
| Martina Murphy, MD @DrMMurphy @btrfly12 @fumikochino Yes!!! I loved this especially seeing as we often have to make dose changes with this medication. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm T2: Which #ASCO22 studies do you think might be of most interest to patients? #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin T1: The ATHENA-MONO trial was very impressive - confirming benefit of #PARPi in the frontline maintenance setting for women with #OvarianCancer #ASCO22 #gyncsm |
| Suzie Siegel @SuzieSiegel T2. @NassifElise's presentation on the gut microbiome & response to #immunotherapy. Eat more fiber! (Unless you're prone to bowel obstructions) #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm RT @ShannonWestin: T1: T1: The ATHENA-MONO trial was very impressive - confirming benefit of #PARPi in the frontline maintenance setting for women with #OvarianCancer #ASCO22 #gyncsm |
| Emeline Aviki, MD, MBA @EmelineAvikiMD RT @womenofteal: T1: T1: For me Emeline Aviki's ,presentation on “Overspending on Dose-Specific Packaging of Lenvatinib for Endometrial Cancer,” which led to @EisaiUS announcing that it will expand its dose exchange program to cover dose reductions. #gyncsm |
| Christina Lizaso @btrfly12 #gyncsm I'm really excited to see more research into this in general! |
| Martina Murphy, MD @DrMMurphy RT @ShannonWestin: T1: T1: The ATHENA-MONO trial was very impressive - confirming benefit of #PARPi in the frontline maintenance setting for women with #OvarianCancer #ASCO22 #gyncsm |
| Emeline Aviki, MD, MBA @EmelineAvikiMD RT @ShannonWestin: T1: T1: The ATHENA-MONO trial was very impressive - confirming benefit of #PARPi in the frontline maintenance setting for women with #OvarianCancer #ASCO22 #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin 💯 - very exciting to see research immediately translate to practice - #gyncsm |
| Dee Sparacio @womenofteal Yes, Listening to the rare cancer presentations like for Neuroendocrine gynecologic tumors was very interesting. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: T2: T2: Which #ASCO22 studies do you think might be of most interest to patients? #gyncsm |
| Dee Sparacio @womenofteal RT @ShannonWestin: T1: T1: The ATHENA-MONO trial was very impressive - confirming benefit of #PARPi in the frontline maintenance setting for women with #OvarianCancer #ASCO22 #gyncsm |
| Dee Sparacio @womenofteal RT @SuzieSiegel: T2. @NassifElise's presentation on the gut microbiome & response to #immunotherapy. Eat more fiber! (Unless you're prone to bowel obstructions) #gyncsm |
| Dee Sparacio @womenofteal @SuzieSiegel @NassifElise After I recurred they told me I was not getting anywhere near the fiber I should be getting. #gyncsm |
| Dee Sparacio @womenofteal RT @ShannonWestin: 💯 - very exciting to see research immediately translate to practice - #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm For those interesting in some of the "headlines" from #SGOmtg, here are some collected articles https://t.co/pbKLJA7wLu https://t.co/KOGztbk1Bx #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @SuzieSiegel: T2. @NassifElise's presentation on the gut microbiome & response to #immunotherapy. Eat more fiber! (Unless you're prone to bowel obstructions) #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @gyncsm: For those interesting in some of the "headlines" from #SGOmtg, here are some collected articles https://t.co/pbKLJA7wLu https://t.co/KOGztbk1Bx #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm T3: What are some of the current "hot topics" in gynecologic cancer research? Are there things still up for debate that patients/survivors/advocates should be aware of? #gyncsm |
| Dee Sparacio @womenofteal T2 study done in Japan : bevacizumab (Avastin) added to first-line chemotherapy led to statistically significant improvements in PFS and (OS) in patients with advanced ovarian clear cell carcinoma (OCCC). Important those those with clear cell #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: For those interesting in some of the "headlines" from #SGOmtg, here are some collected articles https://t.co/pbKLJA7wLu https://t.co/KOGztbk1Bx #gyncsm |
| Tobey @BRCAinfo For me ~ anything that involves #immunotherapy or #targetedtherapy is something I want to know more about in #cancer treatment #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: T3: T3: What are some of the current "hot topics" in gynecologic cancer research? Are there things still up for debate that patients/survivors/advocates should be aware of? #gyncsm |
| Dee Sparacio @womenofteal RT @BRCAinfo: For me ~ anything that involves #immunotherapy or #targetedtherapy is something I want to know more about in #cancer treatment #gyncsm |
| Christina Lizaso @btrfly12 T3: where do things stand with HIPEC? Seems like I see conflicting info #gyncsm |
| Suzie Siegel @SuzieSiegel @btrfly12 For uterine #leiomyosarcoma, it is still being studied. #gyncsm |
| Christina Lizaso @btrfly12 ASCO is huge but there seemed to be a pretty good amount of gynecologic cancer research. You can search through the abstracts at https://t.co/3znkNIiU7J #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @btrfly12: ASCO is huge but there seemed to be a pretty good amount of gynecologic cancer research. You can search through the abstracts at https://t.co/3znkNIiU7J #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @womenofteal: T2 study done in Japan : T2 study done in Japan : bevacizumab (Avastin) added to first-line chemotherapy led to statistically significant improvements in PFS and (OS) in patients with advanced ovarian clear cell carcinoma (OCCC). Important those those with clear cell #gyncsm |
| Christina Lizaso @btrfly12 T3: There seems to finally be some great momentum around endometrial cancer and addressing disparities. That is exciting to see and long overdue. #gyncsm |
| Martina Murphy, MD @DrMMurphy T3 : Better understanding of how we can use molecular profiling in endometrial cancer to make treatment decisions is an important area of ongoing research. Where can we de-escalate treatment and who needs a more aggressive approach? #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin T3: Maximizing #treatment/#maintenance in HRD test negative #OvarianCancer remains a critical unmet need! #gyncsm |
| Dee Sparacio @womenofteal RT @btrfly12: ASCO is huge but there seemed to be a pretty good amount of gynecologic cancer research. You can search through the abstracts at https://t.co/3znkNIiU7J #gyncsm |
| Dee Sparacio @womenofteal RT @btrfly12: T3: T3: There seems to finally be some great momentum around endometrial cancer and addressing disparities. That is exciting to see and long overdue. #gyncsm |
| Martina Murphy, MD @DrMMurphy RT @btrfly12: T3: T3: There seems to finally be some great momentum around endometrial cancer and addressing disparities. That is exciting to see and long overdue. #gyncsm |
| Christina Lizaso @btrfly12 T2: You can search for tweets with both #ASCO22 and #gyncsm to get a glimpse of some of the items covered. |
| Suzie Siegel @SuzieSiegel @btrfly12 But anyone looking for gyn #sarcoma should be sure to look at the sarcoma tracks and posters. #gyncsm |
| Christina Lizaso @btrfly12 RT @ShannonWestin: T3: T3: Maximizing #treatment/#maintenance in HRD test negative #OvarianCancer remains a critical unmet need! #gyncsm |
| Christina Lizaso @btrfly12 RT @DrMMurphy: T3 : T3 : Better understanding of how we can use molecular profiling in endometrial cancer to make treatment decisions is an important area of ongoing research. Where can we de-escalate treatment and who needs a more aggressive approach? #gyncsm |
| Christina Lizaso @btrfly12 RT @SuzieSiegel: @btrfly12 But anyone looking for gyn #sarcoma should be sure to look at the sarcoma tracks and posters. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm T4: What research on palliative care, exercise, nutrition, survivorship do you think will impact patients lives the most - or that survivors should ask their providers about? #gyncsm |
| Gary L. Thompson @garyleethompson #gyncsm friends. #Thisismywhy I stayed in Evanston for #ASCO22 I went to school there, married #theloveofmylife, there. 1st home. Maureen was always Maureen, no matter what the cancer on the inside was called. I see each of you like I saw her. People first, not cancer first. ❤️ |
| Christina Lizaso @btrfly12 @garyleethompson Thanks for all your advocacy and love poured out in her honor #gyncsm |
| Dee Sparacio @womenofteal @btrfly12 It could benefit a subset of patients . Indian HIPEC study of EOC patients, surgery plus HIPEC offers potential benefits in PFS and OS rates, with acceptable rates of morbidity and mortality Ab 5525 #gyncsm |
| Suzie Siegel @SuzieSiegel T4 & T5. Studies showing ethnic minorities, especially black women, are less likely to understand their prognosis, less likely to use hospice and more likely to end up in the ICU. We need better communication! #gyncsm |
| Dee Sparacio @womenofteal RT @DrMMurphy: T3 : T3 : Better understanding of how we can use molecular profiling in endometrial cancer to make treatment decisions is an important area of ongoing research. Where can we de-escalate treatment and who needs a more aggressive approach? #gyncsm |
| Martina Murphy, MD @DrMMurphy T4 : Don’t be afraid to ask about #sexualhealth or body image concerns. We don’t talk about these issues enough and they are so common in the wake of cancer treatment. #gyncsm |
| Dee Sparacio @womenofteal RT @ShannonWestin: T3: T3: Maximizing #treatment/#maintenance in HRD test negative #OvarianCancer remains a critical unmet need! #gyncsm |
| Suzie Siegel @SuzieSiegel RT @DrMMurphy: T4 : T4 : Don’t be afraid to ask about #sexualhealth or body image concerns. We don’t talk about these issues enough and they are so common in the wake of cancer treatment. #gyncsm |
| Christina Lizaso @btrfly12 T4: I saw a study on better genetic education for ovarian cancer patients, but I don't remember a lot of quality of life studies in general. It was nice to see emphasis on financial toxicity though. #gyncsm |
| Christina Lizaso @btrfly12 RT @DrMMurphy: T4 : T4 : Don’t be afraid to ask about #sexualhealth or body image concerns. We don’t talk about these issues enough and they are so common in the wake of cancer treatment. #gyncsm |
| Tobey @BRCAinfo @garyleethompson Gary~ your love ❤️ shines through with every post. Truly sorry for your loss 🙏 Maureen must have been one very special lady. #gyncsm |
 | Jorge Hoegl. MD @oncohoegl RT @JournalCancer: Just published in time for #ASCO22! Molecular classification in #EndometrialCancer: Just published in time for #ASCO22! Molecular classification in #EndometrialCancer: Opportunities for precision oncology in a changing landscape https://t.co/jSpLcDxafe #gyncsm #gyncancer CC: @OncoAlert https://t.co/fxNkYeitij |
| Dee Sparacio @womenofteal @ShannonWestin A few gyn studies are breaking down the reporting of results based on BRCA and HRD status #gyncsm |
| Martina Murphy, MD @DrMMurphy @garyleethompson I love this - thank you for this reminder. People first, always ❤️🙏🏼❤️ #gyncsm |
| Dee Sparacio @womenofteal RT @btrfly12: T2: T2: You can search for tweets with both #ASCO22 and #gyncsm to get a glimpse of some of the items covered. |
| Dee Sparacio @womenofteal RT @SuzieSiegel: @btrfly12 But anyone looking for gyn #sarcoma should be sure to look at the sarcoma tracks and posters. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm RT @DrMMurphy: T4 : T4 : Don’t be afraid to ask about #sexualhealth or body image concerns. We don’t talk about these issues enough and they are so common in the wake of cancer treatment. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: T4: T4: What research on palliative care, exercise, nutrition, survivorship do you think will impact patients lives the most - or that survivors should ask their providers about? #gyncsm |
| Suzie Siegel @SuzieSiegel @btrfly12 Women with uterine #leiomyosarcoma were encouraged to get genetic testing. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm RT @SuzieSiegel: @btrfly12 Women with uterine #leiomyosarcoma were encouraged to get genetic testing. #gyncsm |
| Gary L. Thompson @garyleethompson @btrfly12 I can’t wait until all that I‘ve been working on comes to fruition. I have been cooking something, along with some special friends, for a while now. For those that know me, being quiet is not something I do well! 🤣🤣 You are all too special and too beautiful to hurt. ❤️ #gyncsm |
 | Leigh Pate @LPseattle Hello from Seattle #gyncsm |
| Dee Sparacio @womenofteal RT @SuzieSiegel: T4 & T5. Studies showing ethnic minorities, especially black women, are less likely to understand their prognosis, less likely to use hospice and more likely to end up in the ICU. We need better communication! #gyncsm |
 | Bonnie Donihi @b_donihi RT @ocrahope: Join our community partner @gyncsm for a tweet chat tonight (June 8) at 8 pm ET to discuss recent #gynecologiccancer research updates presented at this year’s #SGOmtg and #ASCO22. |
| GYN Cancer | #GYNCSM @gyncsm T5: Which equity issues were presented at #SGOmtg and #ASCO22? Are we seeing progress? #gyncsm |
| Dee Sparacio @womenofteal RT @DrMMurphy: T4 : T4 : Don’t be afraid to ask about #sexualhealth or body image concerns. We don’t talk about these issues enough and they are so common in the wake of cancer treatment. #gyncsm |
| Dee Sparacio @womenofteal @garyleethompson Your work honors her every day. #gyncsm |
| Christina Lizaso @btrfly12 Genetics and genomics become more and more important for cancer patients to understand and advocate for treatment plans that include testing. #gyncsm |
 | Karen North @mzunrs A4: COUNSELING! Diagnosis, treatment, aftercare, terminal care. It’s important for EVERYONE involved. |
| Suzie Siegel @SuzieSiegel This doesn't fit the topics, but I love this slide from Dr. Brooke Howitt on the ever-growing list of uterine #sarcomas. #gyncsm https://t.co/dA9BF4IqwC |
| Dee Sparacio @womenofteal @fumikochino has done great work in the area of financial toxicity. #gyncsm |
| Dee Sparacio @womenofteal RT @SuzieSiegel: @btrfly12 Women with uterine #leiomyosarcoma were encouraged to get genetic testing. #gyncsm |
| Christina Lizaso @btrfly12 RT @SuzieSiegel: This doesn't fit the topics, but I love this slide from Dr. Brooke Howitt on the ever-growing list of uterine #sarcomas. #gyncsm https://t.co/dA9BF4IqwC |
| Suzie Siegel @SuzieSiegel RT @btrfly12: Genetics and genomics become more and more important for cancer patients to understand and advocate for treatment plans that include testing. #gyncsm |
| Dee Sparacio @womenofteal @LPseattle Hi Leigh, So glad you could stop by. #gyncsm |
| Dee Sparacio @womenofteal RT @SuzieSiegel: This doesn't fit the topics, but I love this slide from Dr. Brooke Howitt on the ever-growing list of uterine #sarcomas. #gyncsm https://t.co/dA9BF4IqwC |
| Christina Lizaso @btrfly12 @SuzieSiegel Visuals are so helpful - especially when cancers are so complex. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: T5: T5: Which equity issues were presented at #SGOmtg and #ASCO22? Are we seeing progress? #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm RT @SuzieSiegel: T4 & T5. Studies showing ethnic minorities, especially black women, are less likely to understand their prognosis, less likely to use hospice and more likely to end up in the ICU. We need better communication! #gyncsm |
| Dee Sparacio @womenofteal T5 Black cancer patients aren’t offered the chance at clinical trials--but over 80% would consider joining one if offered. #gyncsm #ASCO22 The survey was led by Stephanie Walker. |
| Suzie Siegel @SuzieSiegel RT @womenofteal: T5 Black cancer patients aren’t offered the chance at clinical trials--but over 80% would consider joining one if offered. #gyncsm #ASCO22 The survey was led by Stephanie Walker. |
| Dee Sparacio @womenofteal T3 Going back to my hot topic here are 2 grpahics on Antibody drug conjugates. #gyncsm https://t.co/bvuQ4hZ3eD |
| Christina Lizaso @btrfly12 The data on black patients and endometrial cancer is sobering. So was the ASCO study about black patients not being offered clinical trials. Look forward to seeing studies with practical steps and program models. #gyncsm |
| Christina Lizaso @btrfly12 RT @womenofteal: T5 Black cancer patients aren’t offered the chance at clinical trials--but over 80% would consider joining one if offered. #gyncsm #ASCO22 The survey was led by Stephanie Walker. |
| Dee Sparacio @womenofteal RT @btrfly12: The data on black patients and endometrial cancer is sobering. So was the ASCO study about black patients not being offered clinical trials. Look forward to seeing studies with practical steps and program models. #gyncsm |
 | cathygee @cathygee RT @btrfly12: The data on black patients and endometrial cancer is sobering. So was the ASCO study about black patients not being offered clinical trials. Look forward to seeing studies with practical steps and program models. #gyncsm |
 | Fumiko Ladd Chino, MD @fumikochino @womenofteal Thank you! Outside of breast cancer, #gyncsm has some of the best quality #financialtoxicity research. Including by @MLiangMD @EmelineAvikiMD and @K8SLN_MDMBA amongst others |
 | Lisa M Guzzardi, RN @LguzzardiM #COVID-19 Outcomes in Patients With Gynecologic Cancer @CancerTherAdvsr #gyncsm #ASCO22 #womenshealth https://t.co/uHFQ7euHd9 |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @btrfly12: The data on black patients and endometrial cancer is sobering. So was the ASCO study about black patients not being offered clinical trials. Look forward to seeing studies with practical steps and program models. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm T6: For our last topic, we'll let our participants ask any questions they have about recent gynecologic cancer research. Also, what do you want to see research resources focused on? Are there gaps in research you would like to see addressed? #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @womenofteal: T5 Black cancer patients aren’t offered the chance at clinical trials--but over 80% would consider joining one if offered. #gyncsm #ASCO22 The survey was led by Stephanie Walker. |
| GYN Cancer | #GYNCSM @gyncsm RT @LguzzardiM: #COVID-19 Outcomes in Patients With Gynecologic Cancer @CancerTherAdvsr #gyncsm #ASCO22 #womenshealth https://t.co/uHFQ7euHd9 |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @womenofteal: @fumikochino has done great work in the area of financial toxicity. #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @DrMMurphy: T4 : T4 : Don’t be afraid to ask about #sexualhealth or body image concerns. We don’t talk about these issues enough and they are so common in the wake of cancer treatment. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: T6: T6: For our last topic, we'll let our participants ask any questions they have about recent gynecologic cancer research. Also, what do you want to see research resources focused on? Are there gaps in research you would like to see addressed? #gyncsm |
| Sarah Temkin @temkins RT @btrfly12: The data on black patients and endometrial cancer is sobering. So was the ASCO study about black patients not being offered clinical trials. Look forward to seeing studies with practical steps and program models. #gyncsm |
| Suzie Siegel @SuzieSiegel T6. I'd like women with gyn #leiomyosarcoma who are treated in a private practice to know that they can get a second opinion from a #sarcoma medical oncologist. Collaboration helps patients know all of their options for treatment. #gyncsm |
| Dee Sparacio @womenofteal RT @LguzzardiM: #COVID-19 Outcomes in Patients With Gynecologic Cancer @CancerTherAdvsr #gyncsm #ASCO22 #womenshealth https://t.co/uHFQ7euHd9 |
| Dee Sparacio @womenofteal RT @SuzieSiegel: T6. I'd like women with gyn #leiomyosarcoma who are treated in a private practice to know that they can get a second opinion from a #sarcoma medical oncologist. Collaboration helps patients know all of their options for treatment. #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @DrMMurphy: T3 : T3 : Better understanding of how we can use molecular profiling in endometrial cancer to make treatment decisions is an important area of ongoing research. Where can we de-escalate treatment and who needs a more aggressive approach? #gyncsm |
| Christina Lizaso @btrfly12 Any research that those on the chat are involved with? excited about? #gyncsm |
| Christina Lizaso @btrfly12 RT @SuzieSiegel: T6. I'd like women with gyn #leiomyosarcoma who are treated in a private practice to know that they can get a second opinion from a #sarcoma medical oncologist. Collaboration helps patients know all of their options for treatment. #gyncsm |
| Lisa M Guzzardi, RN @LguzzardiM #ClinicalTrial examines combo #immunotherapy for #ovariancancer #gyncsm #ASCO22 #womenshealth https://t.co/0i9VCg02YK |
| Christina Lizaso @btrfly12 RT @LguzzardiM: #ClinicalTrial examines combo #immunotherapy for #ovariancancer #gyncsm #ASCO22 #womenshealth https://t.co/0i9VCg02YK |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @fumikochino: @womenofteal Thank you! Outside of breast cancer, #gyncsm has some of the best quality #financialtoxicity research. Including by @MLiangMD @EmelineAvikiMD and @K8SLN_MDMBA amongst others |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @SuzieSiegel: This doesn't fit the topics, but I love this slide from Dr. Brooke Howitt on the ever-growing list of uterine #sarcomas. #gyncsm https://t.co/dA9BF4IqwC |
| Gary L. Thompson @garyleethompson @womenofteal It was great to have a chance to meet @faceofstage4 at #ASCO22 #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @btrfly12: Genetics and genomics become more and more important for cancer patients to understand and advocate for treatment plans that include testing. #gyncsm |
| Dee Sparacio @womenofteal T6 I heard about women having PARP resistance - like becoming platinum resistant. I wonder how many cycles of PARP does this start? #gyncsm |
| Suzie Siegel @SuzieSiegel @btrfly12 T6. https://t.co/p0wVqj4ZkB is partnering with @SARCtrials to help @JoannaPrzybyl with her research on ctDNA in #leiomyosarcoma. It would be great if ULMS could be better detected before surgery. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm Thanks so much to @womenofteal @SuzieSiegel @LguzzardiM @ShannonWestin @DrMMurphy and others who share research news to #gyncsm and help keep us all informed. |
| Dee Sparacio @womenofteal @garyleethompson @faceofstage4 The part I missed most was getting together with fellow advocates and sharing ideas and offering support . #gyncsm #ASCO22 |
| GYN Cancer | #GYNCSM @gyncsm RT @SuzieSiegel: @btrfly12 T6. https://t.co/p0wVqj4ZkB is partnering with @SARCtrials to help @JoannaPrzybyl with her research on ctDNA in #leiomyosarcoma. It would be great if ULMS could be better detected before surgery. #gyncsm |
| Dee Sparacio @womenofteal RT @SuzieSiegel: @btrfly12 T6. https://t.co/p0wVqj4ZkB is partnering with @SARCtrials to help @JoannaPrzybyl with her research on ctDNA in #leiomyosarcoma. It would be great if ULMS could be better detected before surgery. #gyncsm |
| Sarah Temkin @temkins RT @womenofteal: T3 Going back to my hot topic here are 2 grpahics on Antibody drug conjugates. #gyncsm https://t.co/bvuQ4hZ3eD |
| Lisa M Guzzardi, RN @LguzzardiM New Small Study finds virtual mindfulness-based intervention for sexual health as a feasible treatment option for #ovariancancer & #breastcancer survivors @NewsMedical #gyncsm #bcsm #womenshealth https://t.co/RZDW2qK9uA |
| Dee Sparacio @womenofteal RT @LguzzardiM: #ClinicalTrial examines combo #immunotherapy for #ovariancancer #gyncsm #ASCO22 #womenshealth https://t.co/0i9VCg02YK |
| Suzie Siegel @SuzieSiegel @womenofteal It may depend on the patient, but #sarcoma researchers are interested in this, too. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm RT @LguzzardiM: New Small Study finds virtual mindfulness-based intervention for sexual health as a feasible treatment option for #ovariancancer & #breastcancer survivors @NewsMedical #gyncsm #bcsm #womenshealth https://t.co/RZDW2qK9uA |
| Dee Sparacio @womenofteal RT @gyncsm: Thanks so much to @womenofteal @SuzieSiegel @LguzzardiM @ShannonWestin @DrMMurphy and others who share research news to #gyncsm and help keep us all informed. |
| GYN Cancer | #GYNCSM @gyncsm Thanks for sharing, listening and learning with #gyncsm We use the last few minutes of the chat to wrap up and share what you learned or were reminded of during this chat. You can start your tweet with TIL: standing for “Today I Learned”. |
| Dee Sparacio @womenofteal RT @LguzzardiM: New Small Study finds virtual mindfulness-based intervention for sexual health as a feasible treatment option for #ovariancancer & #breastcancer survivors @NewsMedical #gyncsm #bcsm #womenshealth https://t.co/RZDW2qK9uA |
| Gary L. Thompson @garyleethompson @brcainfo Maureen was the “rest of me.” I will never be able to fully explain her beauty, from the inside out. I tell our stories here: https://t.co/Hq9PUtF8ej. I apologize if I’m disrupting the flow of #gyncsm @btrfly12 So much gr8 knowledge tonight. |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin T6: We are excited about our @MDAndersonNews #PARPi alone trial for women with #OvarianCancer that have #BRCA mutations and need neoadjuvant therapy! Data coming soon 🥰🙌 #gyncsm |
| Christina Lizaso @btrfly12 RT @ShannonWestin: T6: T6: We are excited about our @MDAndersonNews #PARPi alone trial for women with #OvarianCancer that have #BRCA mutations and need neoadjuvant therapy! Data coming soon 🥰🙌 #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @LguzzardiM: New Small Study finds virtual mindfulness-based intervention for sexual health as a feasible treatment option for #ovariancancer & #breastcancer survivors @NewsMedical #gyncsm #bcsm #womenshealth https://t.co/RZDW2qK9uA |
| Tobey @BRCAinfo RT @garyleethompson: @brcainfo Maureen was the “rest of me.” I will never be able to fully explain her beauty, from the inside out. I tell our stories here: https://t.co/Hq9PUtF8ej. I apologize if I’m disrupting the flow of #gyncsm @btrfly12 So much gr8 knowledge tonight. |
| Tobey @BRCAinfo RT @ShannonWestin: T6: T6: We are excited about our @MDAndersonNews #PARPi alone trial for women with #OvarianCancer that have #BRCA mutations and need neoadjuvant therapy! Data coming soon 🥰🙌 #gyncsm |
| Sarah Temkin @temkins RT @ShannonWestin: T6: T6: We are excited about our @MDAndersonNews #PARPi alone trial for women with #OvarianCancer that have #BRCA mutations and need neoadjuvant therapy! Data coming soon 🥰🙌 #gyncsm |
| Dee Sparacio @womenofteal @garyleethompson @faceofstage4 @jillfeldman4 and @AdrienneEcana did awesome in their presentations and representing advocates at #ASCO22. #gyncsm |
| Christina Lizaso @btrfly12 TIL: So appreciative of those in healthcare, including advocates, who use their platforms to share what they are studying and learning. A wonderful unpaid labor that benefits so many. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: Thanks for sharing, listening and learning with #gyncsm We use the last few minutes of the chat to wrap up and share what you learned or were reminded of during this chat. You can start your tweet with TIL: standing for “Today I Learned”. |
| Christina Lizaso @btrfly12 RT @womenofteal: @garyleethompson @faceofstage4 @jillfeldman4 and @AdrienneEcana did awesome in their presentations and representing advocates at #ASCO22. #gyncsm |
| Dee Sparacio @womenofteal RT @ShannonWestin: T6: T6: We are excited about our @MDAndersonNews #PARPi alone trial for women with #OvarianCancer that have #BRCA mutations and need neoadjuvant therapy! Data coming soon 🥰🙌 #gyncsm |
| Dee Sparacio @womenofteal RT @btrfly12: TIL: TIL: So appreciative of those in healthcare, including advocates, who use their platforms to share what they are studying and learning. A wonderful unpaid labor that benefits so many. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm Note there will be no #gyncsm chat in July 2022. Save the date for our next chat on Wednesday, August 10, 8pmET when we’ll discuss "Advocacy for yourself and others". |
| Tobey @BRCAinfo RT @btrfly12: TIL: TIL: So appreciative of those in healthcare, including advocates, who use their platforms to share what they are studying and learning. A wonderful unpaid labor that benefits so many. #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm As always, remember to tweet things of interest with hashtag #gyncsm to keep the conversation going between chats. And visit our blog for chat recaps and other gyn cancer resources. https://t.co/oAfi7Me49e |
| Dee Sparacio @womenofteal TIL That there are researchers from all over the world focused on finding better treatments for gyn cancers #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: Note there will be no #gyncsm chat in July 2022. Save the date for our next chat on Wednesday, August 10, 8pmET when we’ll discuss "Advocacy for yourself and others". |
| Gary L. Thompson @garyleethompson @SuzieSiegel @womenofteal @faceofstage4 @ASCO I dream of hosting a patient conference one day, where we the patients, the caregivers, the grieving, are the hosts and invite others to attend. And pay. 😀 And, I dream of a better term of than patient. ❤️ #gyncsm |
| Christina Lizaso @btrfly12 #gyncsm Resource | Patient Advocate @stigetta report from #SGOmtg via @ocrahope https://t.co/17EzOGSkdc |
| Dee Sparacio @womenofteal Grateful for our #gyncsm co-moderators! @btrfly12 @ShannonWestin @temkins @journeycancer @DrBeckerSchutte |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin Grateful for you and Christina!!! #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @btrfly12: #gyncsm Resource | Patient Advocate @stigetta report from #SGOmtg via @ocrahope https://t.co/17EzOGSkdc |
| Christina Lizaso @btrfly12 Also @womenofteal will have #ovariancancer and other information from ASCO on her blog https://t.co/x79HJYGYsk #gyncsm |
| Dee Sparacio @womenofteal Remember to check https://t.co/Df2f7Okp35 for a transcript of the chat and resources. #gyncsm |
| Christina Lizaso @btrfly12 RT @garyleethompson: @SuzieSiegel @womenofteal @faceofstage4 @ASCO I dream of hosting a patient conference one day, where we the patients, the caregivers, the grieving, are the hosts and invite others to attend. And pay. 😀 And, I dream of a better term of than patient. ❤️ #gyncsm |
| Dee Sparacio @womenofteal @garyleethompson @SuzieSiegel @faceofstage4 @ASCO Hold on to that dream. I'd love to see it happen. #gyncsm |
| Dee Sparacio @womenofteal Till next August Stay well Teal Sisters, healthcare providers and caregivers. #gyncsm |
| Sarah Temkin @temkins RT @ShannonWestin: Grateful for you and Christina!!! #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @womenofteal: Remember to check https://t.co/Df2f7Okp35 for a transcript of the chat and resources. #gyncsm |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @btrfly12: Also @womenofteal will have #ovariancancer and other information from ASCO on her blog https://t.co/x79HJYGYsk #gyncsm |
| GYN Cancer | #GYNCSM @gyncsm Wishing wellness and safety for all. Thanks for being a part of #gyncsm |
| Tobey @BRCAinfo @womenofteal Be well & thank you all. #gyncsm |
| Dee Sparacio @womenofteal RT @gyncsm: Wishing wellness and safety for all. Thanks for being a part of #gyncsm |
| Martina Murphy, MD @DrMMurphy @gyncsm @womenofteal @SuzieSiegel @LguzzardiM @ShannonWestin I learn so much from all of you and your lived experiences. Thankful that you are willing to share and educate! 🙏🏼 #gyncsm |
| Dee Sparacio @womenofteal @DrMMurphy @gyncsm @SuzieSiegel @LguzzardiM @ShannonWestin Thanks so much for joining us tonight and for sharing info from the ASCO meeting. #gyncsm |
| Gary L. Thompson @garyleethompson So glad I tuned in to #gyncsm Summer blessings to all. 🏝☀️ |
| Shannon Westin, MD, MPH, FASCO @ShannonWestin RT @gyncsm: Wishing wellness and safety for all. Thanks for being a part of #gyncsm |
| Dee Sparacio @womenofteal @garyleethompson Glad you joined us too. #gyncsm |
 | NCI Cancer Stats @NCICancerStats The rate of new cases of #UterineCancer is increasing faster for Black women (2.6% per year, 1998-2019) than for White women (0.8% per year, 2002-2019). Visit SEER*Explorer to view more cancer stats: https://t.co/iRlaK2WKhS #GynCSM https://t.co/evmBeMYLrX |
| GYN Cancer | #GYNCSM @gyncsm RT @NCICancerStats: The rate of new cases of #UterineCancer is increasing faster for Black women (2.6% per year, 1998-2019) than for White women (0.8% per year, 2002-2019). Visit SEER*Explorer to view more cancer stats: https://t.co/iRlaK2WKhS #GynCSM https://t.co/evmBeMYLrX |
| Dee Sparacio @womenofteal #gyncsm |
| Dee Sparacio @womenofteal RT @fumikochino: @womenofteal Thank you! Outside of breast cancer, #gyncsm has some of the best quality #financialtoxicity research. Including by @MLiangMD @EmelineAvikiMD and @K8SLN_MDMBA amongst others |
 | Juan C Trabucco @Trabucco65 RT @NCICancerStats: The rate of new cases of #UterineCancer is increasing faster for Black women (2.6% per year, 1998-2019) than for White women (0.8% per year, 2002-2019). Visit SEER*Explorer to view more cancer stats: https://t.co/iRlaK2WKhS #GynCSM https://t.co/evmBeMYLrX |
 | Georgia @_GeorgiaHurst RT @LguzzardiM: #COVID-19 Outcomes in Patients With Gynecologic Cancer @CancerTherAdvsr #gyncsm #ASCO22 #womenshealth https://t.co/uHFQ7euHd9 |
| Georgia @_GeorgiaHurst RT @LguzzardiM: #ClinicalTrial examines combo #immunotherapy for #ovariancancer #gyncsm #ASCO22 #womenshealth https://t.co/0i9VCg02YK |
| GYN Cancer | #GYNCSM @gyncsm RT @womenofteal: #gyncsm |
| Georgia @_GeorgiaHurst RT @LguzzardiM: New Small Study finds virtual mindfulness-based intervention for sexual health as a feasible treatment option for #ovariancancer & #breastcancer survivors @NewsMedical #gyncsm #bcsm #womenshealth https://t.co/RZDW2qK9uA |
| Georgia @_GeorgiaHurst RT @btrfly12: The data on black patients and endometrial cancer is sobering. So was the ASCO study about black patients not being offered clinical trials. Look forward to seeing studies with practical steps and program models. #gyncsm |
| Georgia @_GeorgiaHurst RT @btrfly12: Genetics and genomics become more and more important for cancer patients to understand and advocate for treatment plans that include testing. #gyncsm |
| Georgia @_GeorgiaHurst RT @btrfly12: T2: T2: You can search for tweets with both #ASCO22 and #gyncsm to get a glimpse of some of the items covered. |
 | Tambre Leighn, MA, CPC she/her @tambreleighn RT @womenofteal: #gyncsm |
 | Agus Wörner @Agus_Worner RT @JournalCancer: Just published in time for #ASCO22! Molecular classification in #EndometrialCancer: Just published in time for #ASCO22! Molecular classification in #EndometrialCancer: Opportunities for precision oncology in a changing landscape https://t.co/jSpLcDxafe #gyncsm #gyncancer CC: @OncoAlert https://t.co/fxNkYeitij |
| Dee Sparacio @womenofteal @fumikochino @MLiangMD @EmelineAvikiMD @K8SLN_MDMBA I followed @EmelineAvikiMD after hearing her speak on her work on packaging Lenvatinib at SGO. I will follow @MLiangMD @K8SLN_MDMBA now. #gyncsm |
#GynCSM content from Twitter.